Vimal H. Prajapati, MD, discusses the latest roflumilast cream data from the INTEGUMENT-PED trial for pediatric atopic dermatitis.
Vimal H. Prajapati, MD
Advertisement
Vimal H. Prajapati, MD, of the University of Calgary, Dermatology Research Institute, and Skin Health & Wellness Centre.
Articles by Vimal H. Prajapati, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Sodium supplementation shows no growth benefit in very preterm infants
2
Ibuprofen alone matches combination therapy for pediatric limb injury pain
3
Jonathan Miller, MD, talks starting HPV vaccination earlier to improve cancer prevention
4
Prenatal paracetamol (acetaminophen) not linked to autism, ADHD, or intellectual disability
5